hotspot -WSS

hotspot

author：entertainment 2025-09-28 02:30:07 - browse：36

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： What would happen to your eyes if you looked at the solar eclipse?

WSS

Hospitals use virtual reality to design more inclusive rooms for kids

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Why we need to separate burnout from moral injury in health care

3 hurdles to bringing medical devices to the U.S. market

Gene therapy has helped boys walk. Can scientists keep it that way?

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

The high cost of giving birth even with insurance

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

CDC launches VaccineFinder tool to locate Covid

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lessons Learned: This is why you network to find that industry job you want

Sports medicine is finally prioritizing gender equality

Death of patient in Alzheimer’s trial raises question of possible risks

Guidelines to prevent youth baseball injuries need more muscle

The science behind Janet Jackson's pregnancy at 49

hotspot

Why are elite athletes different? Take a look at their microbes

Why are elite athletes different? Take a look at their microbes

The battle over the Brookhaven Landfill on Long Island

What would happen to your eyes if you looked at the solar eclipse?

In areas with more Black doctors, Black people live longer

Discs beat pads, tampons for heavy menstrual flow, new study shows

focus

explore

leisure time

entertainment